Ben Franklin Technology Partners of Southeastern Pennsylvania is a non-profit organization established in 1982 that focuses on fostering the development and adoption of new technologies in the region. For over 30 years, it has served as a key provider of seed-stage capital, investing more than $170 million in over 1,750 regional technology companies, many of which have achieved industry leadership. In addition to financial support, Ben Franklin promotes university and industry partnerships that facilitate the commercialization of scientific discoveries. The organization is dedicated to strengthening the entrepreneurial ecosystem in Southeastern Pennsylvania, thereby creating jobs and enhancing the technology community.

Robin Hood Ventures is a group of angel investors, focused on early-stage, high-growth companies in the Greater Philadelphia region. We help entrepreneurs build great companies, providing capital, mentoring, expertise and connections to help companies reach their potential. Robin Hood generally invests $250k to $500k, and collaborates with angels, institutions and VCs in our network. We invest as a single entity in businesses we know and understand, in a way that gets deals done. Since 1999, we have invested in over 45 companies in industries including software, medical devices, biotech, internet and financial technology.

DreamIt Health is an accelerator program based in Philadelphia, focused on supporting early-stage startups in the healthcare sector, particularly those involved in digital health, medical devices, and diagnostics. Founded in 2008, it aims to assist companies that have already entered the market and demonstrated some level of revenue or pilot projects. The program connects founders with key players in the healthcare industry, including payers, providers, and pharmaceutical companies, facilitating valuable networking opportunities. Startups benefit from an intensive 3-6 month program that offers seed funding, mentorship, office space, and access to a community of entrepreneurs and experienced advisors. Through this structured approach, DreamIt Health has accelerated numerous startups, helping them to gain customers, establish partnerships, and secure additional funding. The firm has a track record of supporting over 320 startups, which have collectively raised significant follow-on funding and achieved considerable valuations.

SOSV is a global venture capital firm founded in 1995 and headquartered in Princeton, New Jersey. Specializing in seed-to-growth stage investments, SOSV operates multiple accelerator programs worldwide, including HAX for hardware, IndieBio and RebelBio for life sciences, Chinaccelerator and MOX for cross-border internet ventures, Food-X for innovative food solutions, and dlab for blockchain technology. The firm focuses on investments in revolutionary deep technologies aimed at improving human and planetary health, as well as cross-border markets, particularly in Asia. SOSV invests in approximately 150 startups annually, providing support through its resources to accelerate product development and scaling. Over its two-decade history, SOSV has established a strong reputation, consistently ranking among the top venture capital firms globally.

BioAdvance is a venture capital investment firm based in Conshohocken, Pennsylvania, that specializes in funding early-stage life sciences companies in Southeastern Pennsylvania. Established in 2002 with $33 million from the Commonwealth of Pennsylvania's tobacco settlement funds, BioAdvance manages the Greenhouse Fund, which has a total of $50 million available for investment. The firm focuses on therapeutics, medical devices, diagnostics, and platform technologies aimed at improving human health. Since its inception, BioAdvance has committed over $40 million to more than 50 seed-stage companies and 17 pre-seed companies, supporting the development of products to address various health issues, including Alzheimer's disease, cancer, obesity, and respiratory illnesses. By fostering innovation in the healthcare sector, BioAdvance has positioned itself as a leading investor in the region.

A seed- and early-stage venture capital fund.

Alumni Ventures Group, LLC is a venture capital firm founded in 2013 and based in Manchester, New Hampshire, with additional offices in North America. The firm specializes in seed, early-stage, and late-stage pre-IPO investments, focusing on companies that have an alumni connection and an institutional lead investor with relevant expertise. It offers high-quality, diversified venture portfolios to individual investors, particularly accredited alumni from top entrepreneurial schools, who previously lacked access to venture capital opportunities. Alumni Ventures Group invests between $0.01 million and $3 million in various sectors and geographies, without seeking board or observer seats. Additionally, the firm provides focused funds that enable any accredited investor to access a diverse venture portfolio, allowing for investment across different types, sectors, stages, and geographical locations.

Techstars Central LLC, founded in 2006 and based in Boulder, Colorado, operates as a startup accelerator and venture capital firm focused on supporting early-stage technology-oriented companies. It specializes in a mentorship-driven accelerator program, selecting ten startups each summer to participate in a three-month incubation period, offering funding of $120,000 in exchange for equity. Techstars invests primarily in sectors such as fintech, artificial intelligence, blockchain, augmented reality, and IoT, while avoiding investments in medical devices, healthcare technology, and local service-oriented businesses. In addition to its primary accelerator, Techstars has various specialized programs, including those focused on music, retail, mobility, and social impact, with global reach extending to regions such as Africa, Asia, and Latin America. The firm prefers taking minority stakes, typically between six and ten percent, without seeking board representation or investor rights. Techstars has built a robust network of entrepreneurs, mentors, and corporate partners to foster innovation and growth within its portfolio, which includes over 1,000 companies with a significant collective market capitalization.

Dorm Room Fund is the strongest community of entrepreneurial students in the nation. Built by students and powered by First Round, we provide founders with a strong network of investors, world-class mentors, and a $20,000 check.

Broad Street Angels is a Union League affinity club. It is a member-led investors network focusing on early stage, high-growth businesses in the Mid-Atlantic region, as a means of growing the region’s economy, retaining and attracting talent and fostering innovations that strengthen our civic infrastructure.

The Pew Charitable Trusts is a non-profit organization based in Pennsylvania, established in 1948, dedicated to addressing critical public challenges through research, partnerships, technical assistance, and advocacy. It collaborates with a variety of donors, public and private organizations, and engaged citizens to enhance societal well-being. The organization focuses on three primary areas: improving public policy, informing the public, and invigorating civic life. Its work spans multiple fields, including arts and culture, public safety, immigration, infrastructure, election administration, energy, children’s health, food safety, biomedical research, economic mobility, and science. Through its initiatives, The Pew Charitable Trusts aims to foster informed communities and effective policies that contribute to a healthier, safer, and more equitable society.

FirstMark Capital is an early-stage venture capital firm located in New York City, established in 2008 as a spin-out from Pequot Capital Management's venture business. The firm focuses on partnering with exceptional entrepreneurs who are dedicated to addressing significant challenges. FirstMark has cultivated a vibrant community among the innovative teams in its network, facilitating the exchange of ideas and opportunities. The firm has been involved with the founders of notable companies such as Pinterest, Shopify, Airbnb, Riot Games, and InVision, among others. FirstMark primarily invests in information technology companies across the United States, Canada, and Europe.

Gabriel Investments is an early-stage investment group that supports companies in the Philadelphia and surrounding areas by providing capital for high-potential business opportunities. This often implies companies in the pre-revenue and proof of concept stages with potential for high growth, a strong market position and a sustainable competitive advantage. Unlike many early stage funds, Gabriel Investments invests in people and ideas with the perspective of long term ownership. Our mission is to go beyond the value of simply investing dollars by calling on the personal experiences, contacts and areas of expertise of our members to help cultivate your idea, refine your business plan, fill out your management team, develop go-to-market strategies, create strategic partnerships and more.

Adage Capital Management is a Boston-based $8.9B Money Management firm focused on managing S&P 500 assets predominantly for Endowments and Foundations such as Harvard University, Northwestern University, Dartmouth College, the American Red Cross and the Getty Foundation. Adage and its predecessor, the Select Equity Group at the Harvard Management Company, has outperformed the S&P index in each of the last 15 years by an average of 3.5%. The fund is run by Phill Gross, who prior to founding Adage, was a Healthcare and Retail analyst, equity research director and partner at the Harvard Management Company for 18 years..

Andreessen Horowitz LLC, founded in 2009 by Marc Andreessen and Ben Horowitz, is a venture capital firm based in Menlo Park, California. The firm specializes in investing across various stages of company development, from seed and early-stage to growth and late-stage ventures. It primarily targets the technology sector, with a strong emphasis on software, cloud computing, and Internet infrastructure. The firm also explores opportunities in consumer and business Internet applications, mobile software, and data storage, as well as at the intersection of computer science and life sciences, particularly in areas like digital therapeutics and computational medicine. Andreessen Horowitz is known for its significant financial backing, with investments typically ranging from $50,000 to $50 million. The firm has established multiple funds, including early-stage funds that focus on a variety of sectors, while explicitly avoiding investments in clean energy, transportation, and certain life sciences domains.

The Reinvestment Fund (TRF), a national leader in the financing of neighborhood revitalization, has invested $1.2 billion in Mid-Atlantic communities since 1985. A CDFI, TRF finances housing, community facilities, supermarkets, commercial real estate and energy efficiency projects. It also provides public policy expertise by helping clients create actionable solutions and by sharing data and analysis

MissionOG is a Philadelphia-based private equity firm established in 2012 that focuses on early-stage investments in high-growth companies within financial services, technology, and business services. With a strong emphasis on proven business models, MissionOG partners with firms in sectors where its team has extensive operational and investment experience. The firm not only provides financial capital but also leverages a wide network of industry experts to accelerate the growth of its partner companies. MissionOG's latest venture capital fund, launched in 2022, specifically targets investments in the software sector, with individual investments ranging from $8 million to $12 million. The firm's leadership consists of experienced professionals who have successfully built and scaled companies through various growth stages, ultimately leading to successful acquisitions.

The Children's Hospital of Philadelphia, established in 1855 as the first hospital dedicated solely to children's healthcare, has been a pioneer in pediatric medicine. Over its long history, the hospital has been instrumental in numerous medical breakthroughs and innovations that have significantly enhanced pediatric care and saved countless lives. As a non-profit institution, it is committed to delivering exceptional patient care to children and their families. The hospital's foundation supports its mission by providing necessary medical and healthcare facilities, reflecting a steadfast dedication to improving the health and well-being of children in the community and beyond.

HealthCap is a venture capital firm founded in 1996 and based in Stockholm, Sweden, specializing in investments within the life sciences sector. With over €800 million in committed capital, it is one of the largest providers of venture capital in Europe focused on healthcare and biotechnology. The firm targets both early and late-stage investments, seeking transformative therapies and innovative technologies that address high unmet medical needs. HealthCap invests globally, primarily in pharmaceuticals, biotechnology, and related fields, and aims to act as a lead investor, often acquiring minority stakes and seeking board representation in its portfolio companies. Since its inception, HealthCap has managed multiple funds and has completed numerous investments, demonstrating its commitment to advancing medical practices and improving patient outcomes.

New Rhein is a private equity investment firm based in Philadelphia, specializing in healthcare therapeutics and medical devices. The firm is comprised of partners and associates with extensive operational and transactional experience in the industry. New Rhein focuses on investing in businesses that apply proven products in new ways, such as new indications and dosage forms. The company assembles syndicates of investors who possess a wealth of experience and a broad network of relationships, which they leverage to support portfolio companies in various areas, including development, regulatory affairs, reimbursement, marketing, and contract manufacturing. Additionally, New Rhein assists its portfolio companies in understanding the preferences of strategic partners, helping them to build a compelling value proposition. Previous investments have included sectors such as ophthalmic pharmaceuticals, molecular diagnostics, and respiratory drug/device inhalers.

Campbell Soup Company, founded in 1869, is a prominent manufacturer and marketer of branded convenience food products based in the United States. The company operates through five segments: U.S. Simple Meals, Global Baking and Snacking, International Simple Meals and Beverages, U.S. Beverages, and North America Foodservice. Campbell's diverse product portfolio includes soups, meals, beverages, snacks, and packaged fresh foods, which are sold worldwide. The company has expanded its operations through several acquisitions, such as Bolthouse Farms and Plum Organics, enhancing its presence in the health-focused food segment. Campbell also divested its European simple meals business to streamline its focus on core markets and offerings.

Comcast Ventures is the venture capital arm of Comcast Corporation, focusing on investments across various stages of company development, from seed to late-stage growth. The firm targets sectors such as advertising, consumer technology, enterprise services, and infrastructure, with particular interests in digital advertising, video networks, and broadband technologies. Investments span a wide range of industries including media, cybersecurity, healthcare, fintech, and artificial intelligence. Comcast Ventures typically seeks to invest between $2 million and $25 million and prefers to take a minority stake, often acting as a lead investor while also co-investing with other venture capital funds. The firm actively supports underrepresented ethnic minority entrepreneurs and emphasizes investments in the United States and Canada, particularly in New York. Established in January 1999 and based in San Francisco, Comcast Ventures also operates offices in New York, Los Angeles, Philadelphia, and Santa Monica.

Agent Capital is a venture capital firm based in Waltham, Massachusetts, founded in 2017. The firm specializes in early-to-late stage investments in healthcare-related companies throughout the United States. Its investment focus includes sectors such as immunology, neuroscience, oncology, ophthalmology, and rare diseases. As a Registered Investment Adviser, Agent Capital is dedicated to supporting the growth of innovative healthcare solutions.

GV Management Company, LLC, established in 2009 as the venture capital arm of Alphabet Inc., specializes in investments across various stages, including seed, early, and late-stage funding. Based in Mountain View, California, with additional offices in Boston, New York, Seattle, Cambridge, and London, GV focuses on sectors such as life sciences, healthcare, artificial intelligence, robotics, transportation, cybersecurity, and agriculture. The firm has invested in over 300 companies, aiming to drive innovation and improve lives. GV seeks to make investments of up to $50 million, while offering early-stage startups funding of up to $250,000, typically taking minority stakes in these companies. Through its extensive network, GV provides startups with unique access to technology and talent, enhancing their potential for success.

IP Group, founded in 2001 and based in London, specializes in the commercialization of intellectual property derived from research-intensive institutions. The company focuses on identifying and developing valuable intellectual property and forming strategic commercial partnerships to maximize its potential. With a strong background in industry and finance, IP Group offers financial, strategic, and commercial expertise to its clients on an international scale. The firm has established a solid track record of delivering significant results for its portfolio companies, partners, and shareholders, particularly in sectors such as pharmaceuticals and biotechnology. Through its comprehensive approach, IP Group aims to create long-term value while fostering innovation in the marketplace.

First Round Capital is a seed-stage venture capital firm founded in 2004 and headquartered in San Francisco, with additional offices in Philadelphia and New York. The firm focuses on pre-seed, seed, and Series A investments in technology, healthcare, and consumer sectors, often providing the first outside capital for nascent companies. First Round Capital has a track record of supporting notable startups, including Uber, Square, and Warby Parker. The firm distinguishes itself by actively engaging with its portfolio companies and offering a range of tailored services, including custom software and community-building experiences, to help entrepreneurs grow their businesses. With a typical initial investment of around $500,000, First Round Capital has facilitated substantial follow-on funding, enabling its community members to raise over $2.5 billion in additional capital. The firm has also pioneered innovative investment structures, such as a VC-sponsored Exchange Fund, which allows entrepreneurs to share in the performance of their collective investments.

2048 Ventures is a New York-based venture capital firm that specializes in early-stage investments in technology companies across the United States and Canada. The firm primarily focuses on pre-seed funding and seeks to partner with both first-time and experienced founders who possess a first-time founder mindset. 2048 Ventures emphasizes differentiation and defensibility through technology, looking for companies with strong founder-market fit, vision, and early traction. Its investment portfolio spans various sectors, including artificial intelligence, fintech, cybersecurity, healthcare technology, enterprise software, and consumer businesses. While the firm is geographically agnostic, it primarily invests in cities such as New York, Boston, Austin, Atlanta, Toronto, and Pittsburgh, leveraging its extensive network of advisors and investors to support the growth of its portfolio companies.

Darco Capital, L.P. is a principal investment firm and family office based in Philadelphia, Pennsylvania, founded in 2010. It focuses on investing in technology and consumer businesses, including startups and established companies. The firm is the investment vehicle of David Adelman and aims to identify and support promising ventures within these sectors.

Versant Ventures is a prominent healthcare investment firm headquartered in California, specializing in medical devices, biotechnology, and pharmaceuticals. Established in 1999, the firm manages approximately $2.3 billion and invests across all stages of company development, with a strong focus on discovering and developing innovative therapeutics. Versant has a global presence with offices in Canada, the U.S., and Europe, and its team comprises professionals with extensive investment, operational, and scientific expertise, allowing for a proactive approach to building companies. Since its inception, Versant has successfully facilitated the growth of over 65 companies, leading to numerous acquisitions and public offerings.

MentorTech Ventures is a Philadelphia-based venture capital firm established in 2005 that focuses on seed- and early-stage investments. The firm primarily invests in companies affiliated with the University of Pennsylvania, often led by founders or managers who are students, faculty, or alumni of the institution. MentorTech Ventures targets sectors such as information technology, physical sciences, healthcare devices, and software. The firm has managed multiple funds, including MentorTech Ventures II and III, which aimed to support innovative companies in the United States. By leveraging its ties to the university ecosystem, MentorTech Ventures seeks to capitalize on emerging technologies and intellectual properties developed within this academic environment.

The University of Pennsylvania, founded in 1740 and located in Philadelphia, is a prestigious non-profit educational institution known for its commitment to producing future leaders through comprehensive liberal arts and sciences education. It offers over 140 undergraduate programs and more than 180 graduate programs across diverse fields, including anthropology, engineering, and women’s studies. The university emphasizes social outreach, providing over 300 volunteer opportunities and 160 academic community service courses, coordinated through initiatives like the Civic House and the Fox Leadership program. As a member of the Ivy League, Penn maintains competitive admissions standards that require prospective students to submit both the University application and standardized test scores. Financial aid is awarded based on need, ensuring access to education without the burden of loans. The university's focus on research and community service enriches the academic experience, fostering a spirit of engagement and leadership among its students.

SRI Capital is an early-stage venture capital firm founded in 2007, with headquarters in Philadelphia and an office in India. The firm focuses on funding innovative technology startups, primarily in India and the United States, while also considering global companies aiming to enter the Indian consumer market. SRI Capital's primary investment areas include enterprise software and deep tech, targeting startups that develop scalable applications for the U.S. market, Indian startups that leverage the Digital India initiative for middle-income consumers, and cross-border innovations to serve the Indian market. Typically, SRI Capital acts as the first institutional investor, committing between $500,000 and $1,000,000 for a meaningful minority stake, and often leads investment rounds. The firm is known for its active involvement with portfolio companies, providing support beyond financial investment, and may invest up to $5,000,000 in any one company.

Rittenhouse Ventures is a Philadelphia-based early-stage venture fund established in 2006, specializing in capital-efficient investments in emerging technology companies within Pennsylvania and the Mid-Atlantic region. The firm primarily focuses on small financing rounds, typically ranging from $1 to $3 million, targeting early-stage information technology companies that leverage innovative technologies to develop significant business opportunities. While Rittenhouse Ventures invests across the entire information technology spectrum, it places a particular emphasis on Healthcare Information Technology and Pharmaceutical IT. Additionally, the firm explores opportunities in Technology-Enabled Services, specifically in sectors such as Financial Services Information Technology and Outsourced Business Services.

NextStage Capital, established in 2006 and based in Pennsylvania, specializes in identifying early-stage investment opportunities in the Mid-Atlantic region, particularly within the technology sector. The firm seeks talented entrepreneurs with innovative, validated technology solutions and aims to enhance their company value through strategic support. With partners who have invested over $175 million in early-stage capital, NextStage Capital brings extensive experience from numerous successful exits and challenging scenarios. The firm emphasizes the importance of key hires and integrates recruiting into its investment model, partnering with TWC Group to help portfolio companies attract experienced executives. By providing capital, industry contacts, and operational expertise, NextStage Capital focuses on fostering long-term partnerships with entrepreneurs, enabling them to concentrate on their core competencies while the firm aids in launching their companies toward success.

F Prime, Inc. is a venture capital firm based in Cambridge, Massachusetts, with additional offices in San Francisco and London. Founded in 1969, it is part of the legacy of Fidelity Investments, one of the largest asset management firms in the world. F Prime focuses on investing in North American and European companies across various sectors, including healthcare, life sciences, medtech, technology, and health information technology. The firm operates several specialized funds, such as those dedicated to healthcare and life sciences, which aim to support early-stage companies in these industries. With a commitment to fostering entrepreneurship, F Prime leverages its extensive insights, domain expertise, and relationships to assist entrepreneurs in building impactful companies, all while avoiding the pressures of external fundraising.

Synetro Group, L.L.C. is a private equity and venture capital firm based in Chicago, Illinois, established in 2000. The firm specializes in investing in startups and early-stage companies, particularly in sectors such as Internet B2B, web-based services, business services, high-end branded manufacturing, insurance, and software. Synetro Group typically invests between $0.25 million and $6 million in early-stage companies with a minimum of $1 million in sales, and up to $50 million in equity for mature companies with sales ranging from $25 million to $100 million. The firm focuses on strategic investments, including minority, majority, and control stakes, while also playing an advisory role in its portfolio companies. Additionally, Synetro Group avoids investments in life sciences, retail, restaurants, commodities, energy, and oil and gas sectors, concentrating its efforts primarily in the Midwest, particularly in Chicago and Philadelphia.

Backswing Ventures is a venture capital firm based in Philadelphia that was founded in 2020. With a fund size of $50 million, it focuses on investing in early-stage companies across various industries, including defense, technology, data, and healthcare technology. The firm prioritizes founders and their teams, seeking those with strong conviction and passion for their business. Backswing Ventures aims to support companies that are either currently profitable or projected to achieve profitability within 12 months of investment. The firm is dedicated to identifying and investing in disruptive businesses that have the potential to make a lasting impact in their respective sectors, leveraging the diverse backgrounds and networks of its founders to source and evaluate opportunities effectively.

Intel Corporation is a leading global designer and manufacturer of semiconductor technologies, focused on powering the cloud, smart devices, and connected technologies. Founded in 1968 and headquartered in Santa Clara, California, Intel operates through various segments including Data Center Group, Internet of Things Group, Mobileye, and Client Computing Group, among others. The company offers a range of products such as central processing units, chipsets, accelerators, and memory solutions, catering to original equipment manufacturers, original design manufacturers, and cloud service providers. Intel has been transitioning from a PC-centric to a data-centric business model, emphasizing advancements in performance, power, and connectivity across various workloads. With a strong commitment to innovation, Intel also invests through Intel Capital in startups that drive technologies in cloud infrastructure, artificial intelligence, and 5G, among others. The company’s collaborations with prominent organizations aim to develop privacy-preserving analytics and enhance computing capabilities. As one of the largest semiconductor manufacturers by revenue, Intel continues to shape the future of computing and communications.

General Catalyst Group Management, LLC is a private equity and venture capital firm founded in 2000 and based in Cambridge, Massachusetts, with additional offices in North America and Europe. The firm specializes in early-stage and growth equity investments, focusing on a diverse range of sectors including technology, advanced materials, clean energy, cybersecurity, healthcare, and consumer services. General Catalyst seeks to invest in companies that demonstrate strong growth potential, typically targeting those with an EBITDA between $3 million and $30 million and minimum revenues of $10 million. The firm has managed eight venture capital funds with approximately $3.75 billion in capital commitments. It emphasizes building lasting relationships with entrepreneurs and provides mentorship to foster success, enabling companies to scale effectively. General Catalyst primarily invests in North America and Australia, with a preference for seed investments in Silicon Valley, New York, and Boston.

SWaN & Legend Venture Partners is a Virginia-based private equity firm established in 2012 through the merger of SWaN Investors and Legend Ventures. The firm specializes in investing in early and growth stage technology-enabled consumer brands across various sectors, including retail, education, food and hospitality, and sports and entertainment. With a management team experienced in creating significant value, the partners are dedicated to actively collaborating with organizational leadership to build trusted brands that resonate with consumers. SWaN & Legend prioritizes ethical practices in its investments, emphasizing the fair treatment of employees, consumers, vendors, and communities.

Scale Management, LLC, also known as Scale Venture Partners, is a venture capital firm based in Foster City, California, founded in 2000. The firm specializes in early-stage investments in technology companies, particularly in sectors such as artificial intelligence, fintech, cloud computing, and software as a service (SaaS). With approximately $1.3 billion in assets under management, Scale focuses on startups that are innovating in business software, leveraging automation and machine learning. The firm offers a value acceleration platform that assists founders in developing go-to-market strategies, as well as access to a proprietary dataset of operational metrics from over 1,000 private companies. This resources allows entrepreneurs to benchmark their performance while scaling their businesses. Scale Venture Partners aims to partner with entrepreneurs to foster growth from initial customer acquisition to achieving market leadership.

OrbiMed Advisors LLC is a healthcare-focused investment firm founded in 1989, managing approximately $5 billion in assets. The firm specializes in a range of investment strategies, including private equity, venture capital, and public equity, targeting companies across the healthcare spectrum—from startups to large multinational corporations. OrbiMed invests in various sectors within the healthcare industry, including pharmaceuticals, biotechnology, life sciences, medical devices, and health IT. The firm typically invests between $3 million and $150 million, often seeking majority stakes in its portfolio companies. With a global investment approach, OrbiMed operates from offices in New York, San Francisco, Mumbai, Herzliya, Shanghai, West Kowloon, and Luxembourg, focusing on opportunities in North America, Europe, Asia, and Israel. Its investment strategies are underpinned by fundamental analysis, encompassing investments in public equity, fixed income, and alternative markets.

Osage Partners LLC is a private equity and venture capital firm established in 1990, based in Bala Cynwyd, Pennsylvania, with an additional office in Princeton, New Jersey. The firm specializes in early-stage, mid-venture, and late-stage investments, primarily focusing on technology and healthcare sectors. It seeks to invest in a wide range of areas including business-to-business software, life sciences, healthcare IT, medical devices, diagnostics, and advanced materials. Osage Partners typically invests between $1 million to $4 million in companies with annual revenues ranging from $500,000 to $3 million, with a preference for leading investment rounds. The firm emphasizes partnerships with research universities to support startups that commercialize university technologies, having collaborated with over 80 institutions, including many of the top research universities in the U.S. Osage Partners is committed to actively participating in the governance of its portfolio companies to foster growth and innovation.

Cooley is an independent full-service law firm founded in 1920 and headquartered in Palo Alto, California. With over 700 attorneys across eleven offices in the United States and China, Cooley offers legal advisory services in various areas, including mergers and acquisitions, restructuring, equity and debt financing, estate planning, and fund formation. The firm serves a diverse clientele that includes entrepreneurs, investors, and established companies, addressing complex legal issues where innovation intersects with the law. Cooley has expertise in industries such as healthcare, energy, life sciences, education, and media, making it a key partner for clients involved in transformative deals and significant litigation.

Ridge Ventures, previously known as IDG Ventures SF, is a venture capital and private equity firm based in San Francisco, California. Founded in 1997, the firm specializes in seed, early stage, and bridge investments, primarily focusing on enterprise IT and consumer companies. Ridge Ventures invests in sectors such as new media, e-commerce, information technology, and advanced technologies, with particular attention to media, Internet infrastructure, and enterprise software. The firm typically invests between $0.25 million and $5 million per round, often leading or co-leading these investments, and it is particularly inclined towards Series A deals. Ridge Ventures seeks to partner with experienced founders who are innovating in software and creating new distribution models and user experiences. With a belief that significant problems present substantial opportunities, the firm actively supports startups in areas such as SaaS, adtech, gaming, and e-commerce.

Science Center is an influential organization based in Philadelphia, Pennsylvania, dedicated to accelerating the commercialization of technology and fostering regional economic development. Established in 1963, it is the largest urban research park in the United States and plays a pivotal role in bringing together innovations, scientists, entrepreneurs, and funding. The organization operates Science Center Ventures, which focuses on investing in life sciences and technology companies. Through its Port business incubators, the Science Center has supported the growth of graduate organizations and current residents that have collectively created over 15,000 jobs in the Greater Philadelphia region. These efforts contribute significantly to the local economy, generating more than $9 billion annually.

Lenfest Foundation, established in 2000 and based in Pennsylvania, is a non-profit organization dedicated to empowering young people, particularly in Philadelphia. The foundation focuses on grant-making initiatives that enhance education, job training, and mentoring programs, ensuring that youth acquire the knowledge and skills necessary for fulfilling and productive lives. With a commitment to fostering promising strategies, Lenfest Foundation aims to create lasting impacts on the lives of young individuals, preparing them to thrive in their future careers. The organization operates with a strong belief in the potential of the next generation and recognizes the urgency of providing them with the opportunities needed to succeed.

Temple University, founded in 1884 and located in Philadelphia, Pennsylvania, is one of the largest four-year institutions in the United States, offering a wide range of academic programs and research opportunities. The university provides over 300 academic programs leading to bachelor’s, master’s, and doctoral degrees, with a strong emphasis on professional education in fields such as medicine, law, dentistry, architecture, and pharmacy. Additionally, Temple is recognized for its programs in business, communications, education, art, music, and science. Research plays a vital role at the institution, with centers dedicated to various topics including aging, biostatistics, and obesity. The university fosters a vibrant student life, featuring over 200 student organizations, a student newspaper, and a student-run radio station. Admissions are selective for both undergraduate and graduate programs, with various financial aid options available to eligible students. Temple University also manages an endowment fund, which supports its operations and helps maintain the purchasing power of its financial resources for future needs.

DeSimone Group Investments, LLC is a venture capital firm based in Cherry Hill, New Jersey, focused on providing growth funding to early to mid-stage companies in the Philadelphia and tri-state region. The firm specializes in the industrial sector, targeting investments in manufactured products, renewable energies, and engineered solutions that promote efficiency. DeSimone Group Investments combines financial support with strategic business planning and mentorship, thereby assisting entrepreneurs in developing their companies. The firm also connects its portfolio companies with a network of regional funding sources and collaborates with angel investor groups and other venture capital firms to facilitate additional funding. The DeSimone family has a long-standing business history in Southern New Jersey, which provides a foundation of experience and values that guide the firm's investment philosophy.

Blackstone is a global investment and advisory firm that specializes in alternative asset management, serving a diverse range of institutional clients, including pension funds, endowments, and insurance companies. Founded in 1985 by Stephen A. Schwarzman and Peter G. Peterson, the firm has grown to employ nearly 1,800 people across 24 offices worldwide. Blackstone manages a broad portfolio that encompasses private equity, real estate, credit, and hedge fund investments, preserving and protecting significant assets for its clients. The firm's investment strategies are informed by thorough qualitative and quantitative analysis, focusing on creating long-term value for stakeholders. Additionally, Blackstone operates in the life sciences sector, partnering with pharmaceutical and biotechnology companies to address funding gaps in bringing innovative healthcare solutions to market. The firm emphasizes a strong partnership culture and integrity in its operations, striving to deliver exceptional performance across its diverse investment vehicles.